These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

207 related items for PubMed ID: 30484723

  • 1. KL-6 is a long-term disease-activity biomarker for interstitial lung disease associated with polymyositis/dermatomyositis, but is not a short-term disease-activity biomarker.
    Hanaoka M, Katsumata Y, Kawasumi H, Kawaguchi Y, Yamanaka H.
    Mod Rheumatol; 2019 Jul; 29(4):625-632. PubMed ID: 30484723
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Serum KL-6 is associated with the severity of interstitial lung disease in Chinese patients with polymyositis and dermatomyositis.
    Hu C, Wu C, Yang E, Huang H, Xu D, Hou Y, Zhao J, Li M, Xu Z, Zeng X, Wang Q.
    Clin Rheumatol; 2019 Aug; 38(8):2181-2187. PubMed ID: 30888566
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Clinical Utility of YKL-40 in Polymyositis/dermatomyositis-associated Interstitial Lung Disease.
    Hozumi H, Fujisawa T, Enomoto N, Nakashima R, Enomoto Y, Suzuki Y, Kono M, Karayama M, Furuhashi K, Murakami A, Inui N, Nakamura Y, Mimori T, Suda T.
    J Rheumatol; 2017 Sep; 44(9):1394-1401. PubMed ID: 28711881
    [Abstract] [Full Text] [Related]

  • 8. Clinical significance of soluble CD163 in polymyositis-related or dermatomyositis-related interstitial lung disease.
    Enomoto Y, Suzuki Y, Hozumi H, Mori K, Kono M, Karayama M, Furuhashi K, Fujisawa T, Enomoto N, Nakamura Y, Inui N, Suzuki D, Ogawa N, Nakashima R, Mimori T, Iwashita T, Suda T.
    Arthritis Res Ther; 2017 Jan 19; 19(1):9. PubMed ID: 28103926
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Surfactant proteins-A and D as important serum markers for interstitial lung disease in patients with polymyositis or dermatomyositis].
    Chen F, Shu XM, Wang DX, Xie Y, Wang GC.
    Zhonghua Yi Xue Za Zhi; 2012 Aug 21; 92(31):2182-5. PubMed ID: 23158422
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Association of serum KL-6 levels with interstitial lung disease in patients with connective tissue disease: a cross-sectional study.
    Oguz EO, Kucuksahin O, Turgay M, Yildizgoren MT, Ates A, Demir N, Kumbasar OO, Kinikli G, Duzgun N.
    Clin Rheumatol; 2016 Mar 21; 35(3):663-6. PubMed ID: 26758437
    [Abstract] [Full Text] [Related]

  • 15. KL-6 is a potential marker for interstitial lung disease associated with juvenile dermatomyositis.
    Kobayashi I, Ono S, Kawamura N, Okano M, Miyazawa K, Shibuya H, Kobayashi K.
    J Pediatr; 2001 Feb 21; 138(2):274-6. PubMed ID: 11174630
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Predictive factors for long-term outcome in polymyositis/dermatomyositis-associated interstitial lung diseases.
    Fujisawa T, Hozumi H, Kono M, Enomoto N, Nakamura Y, Inui N, Nakashima R, Imura Y, Mimori T, Suda T.
    Respir Investig; 2017 Mar 21; 55(2):130-137. PubMed ID: 28274528
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The predictive prognostic factors for polymyositis/dermatomyositis-associated interstitial lung disease.
    Sugiyama Y, Yoshimi R, Tamura M, Takeno M, Kunishita Y, Kishimoto D, Yoshioka Y, Kobayashi K, Takase-Minegishi K, Watanabe T, Hamada N, Nagai H, Tsuchida N, Soejima Y, Nakano H, Kamiyama R, Uehara T, Kirino Y, Sekiguchi A, Ihata A, Ohno S, Nagaoka S, Nakajima H.
    Arthritis Res Ther; 2018 Jan 11; 20(1):7. PubMed ID: 29325580
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.